image_award_gold_left

100

International
Broker Awards

image_award_gold_right

Biotech ETFs

Invest in Biotech ETFs at incredibly low fees. Find out why more than 2.5 million investors choose us.

Open an account

Invest in biotech ETFs with DEGIRO

Are you interested in biotech or do you believe a biotech ETF would be a good fit for your portfolio? Investing in ETFs is an easy way to increase the diversification of your portfolio. On our platform, you can find a wide selection of biotech ETFs.

Not every biotech ETF is the same. ETFs differ from each other in several ways, such as fund size, price, risk and underlying value. For example, they may track different companies or indices. Also, some may pay dividends and others may not.

These are the 5 most traded biotech ETFs by our clients in 2022.

ETF name ISIN
iShares Nasdaq US Biotechnology ETF USD Acc IE00BYXG2H39
Invesco Nasdaq Biotech UCITS ETF Acc IE00BQ70R696
iShares Nasdaq US Biotechnology ETF USD Dist IE00BDZVHG35
iShares Nasdaq Biotechnology ETF US4642875565
SPDR S&P Biotech ETF US78464A8707

ETF naam

ISIN

iShares Nasdaq US Biotechnology ETF USD Acc

IE00BYXG2H39

Invesco Nasdaq Biotech UCITS ETF Acc

IE00BQ70R696

iShares Nasdaq US Biotechnology ETF USD Dist

IE00BDZVHG35

iShares Nasdaq Biotechnology Etf

US4642875565

SPDR S&P Biotech ETF

US78464A8707

The information on this page is intended for informational purposes only and does not provide any recommendations or financial advice.

Investing in ETFs, accessible to everyone

Exchange-traded funds (ETFs) make investing easier because they are the perfect product to quickly build a diversified portfolio. We offer a wide range of ETFs trading on 19 major exchanges. Whether you want to invest in local ETFs or global ETFs, investing opportunities are abundant. We even offer a Core Selection of ETFs for which commission costs, at least for your first monthly trade in each ETF, are on the house. You only pay a €1 handling fee per transaction. Currency, connectivity or external product & spread costs may apply. The ETF Core Selection is subject to change and falls under a Fair Use Policy. Please check the ETF Core Selection before you invest. See the list here.

With our low fees and wide trading possibilities, we make investing in ETFs accessible to everyone. See a complete overview of our unprecedented rates here.

Open an account

Selected ETFs

COMMISSION

€0

+

HANDLING

€1

Worldwide

COMMISSION

€2

+

HANDLING

€1

*Fees per trade. Currency, connectivity or external product & spread costs may apply. Find out more on our fees page. The ETF Core Selection is subject to change and falls under a Fair Use Policy.

In 2022, the three most traded Core Selection ETFs were either from Vanguard or iShares:

Vanguard S&P 500 UCITS ETF USD
IE00B3XXRP09

Vanguard FTSE All-World UCITS ETF USD Dis
IE00B3RBWM25

iShares Core MSCI World UCITS ETF USD (Acc)
IE00B4L5Y983

What is an ETF?

ETFs, also known as trackers, are funds that follow the performance of an index, commodity, bond or composition of products. Unlike some other funds, ETFs are bought and sold on a stock exchange. Would you like to learn more about ETFs? Read our ETF article for all you need to know.

Open an account
ETF

Biotech

Biotech is short for biotechnology and is the sector that deals with turning biology knowledge into technological applications.

Companies that operate in the biotech sector develop new or more efficient methods of making products using biological processes. Biotech solutions are used in medicine, agriculture and various other industries.

Like pharmaceutical companies, biotech companies sometimes produce drugs. However, there is a difference between the two industries: drugs from biotech companies come from living organisms, and those from pharmaceutical companies have a chemical base.

Biotech
Vierkant

Why invest in biotech ETFs?

Investing in biotech means investing in innovation, science and digital applications combined. Biotech companies produce many different products. You’ll find everything from COVID-19 treatments and flu vaccines to biodegradable plastic and living algae that purify water in this sector. A common denominator of all these different biotech companies is that they constantly innovate. This industry wants to find solutions for the future.

The share price of biotech companies can sometimes fluctuate considerably. This is a result of how biotech companies work. Anything can happen during the development phase. If a product turns out to be less effective or is rejected, the price can drop quickly. But once a product proves to be effective or is approved by regulators, the stock price can skyrocket. These price fluctuations can be easily hedged with ETFs. With a biotech ETF, you can invest in multiple biotech companies at the same time. This way, you can spread the risk and any price fluctuations of one company have less effect on your overall portfolio.

Biotech companies are complex and challenging due to the multitude of factors an investor must consider. ETFs that are more specific, such as biotech ETFs, compared to those that are broader, such as world ETFs, the performance will depend more on the specific sector or industry the ETF tracks.

The information on this page is intended for informational purposes only and does not provide any recommendations or financial advice.

More than 100 international awards

We strive to offer the best product by being innovative and staying on top of safety and security. These awards are proof of this hard work and the reason we are the market leader in Europe.

Best-broker-2023-Cashcow Netherlands

Best Broker

Cash Cow 2023

UK-award United Kingdom

Best Low-Cost Stockbroker

FT & IC 2022

PT-award Portugal

Best stockbroker

Rankia 2022

DE-award Germany

Fairest online broker

NTV 2020

Your investment journey starts here

Open a free account and join over 2.5 million investors worldwide on our user-friendly platform.

Note:
Investing involves risks. You can lose your invested funds. We advise you to only invest in financial products which match your knowledge and experience. This is not investment advice.

Investing places your capital at risk. Read our full warning here.

icon_close

We want to empower people to become the best investors they can be. By offering a universe of possibilities and choices on our user-friendly platform, we are removing barriers to make investing accessible to everyone: beginners or experts. You get access to a wide variety of products on more than 50 global exchanges to have the freedom to invest the way you like. In our world, you also get great value for money. So, without compromising an inch on the quality, security and range of our investment services, we offer incredibly low fees. Prioritising your needs has helped us become the leading European online broker. Our 2.5+ million clients and 100+ international awards are proof of our success.

This communication is issued on behalf of flatexDEGIRO Bank AG and has been approved as a financial promotion on 3rd August 2023, for the purposes of section 21 of the Financial Services Market Act 2000 (FSMA), by Resolution Compliance Limited which is authorised and regulated by the Financial Conduct Authority (FRN:574048). flatexDEGIRO Bank AG is an overseas firm which is not authorised by the Financial Conduct Authority. This means that the FCA Rules made under FSMA for the protection of retail clients do not apply to the services provided by flatexDEGIRO Bank AG but investors are instead protected under applicable German law and Dutch law rules that apply to flatexDEGIRO Bank AG. Investors are not protected by the UK Financial Services Compensation Scheme.

flatexDEGIRO Bank Dutch Branch, a foreign branch of flatexDEGIRO Bank AG | Amstelplein 1, 1096HA Amsterdam | phone: +31 20 261 3072 | e-mail: clients@degiro.com | flatexDEGIRO Bank Dutch Branch is registered with the Dutch Chamber of Commerce under number 82510245. | flatexDEGIRO Bank Dutch Branch, trading under the name DEGIRO, is the Dutch branch of flatexDEGIRO Bank AG. flatexDEGIRO Bank AG is an overseas company primarily supervised by the German financial regulator (BaFin). In the Netherlands, flatexDEGIRO Bank Dutch Branch is registered with DNB and supervised by AFM and DNB. | flatexDEGIRO Bank AG is a licensed German bank supervised by the German financial regulator and registered with the German Chamber of Commerce under number HRB 105687.

Logo

Terms and conditions for the £100 transaction fees offer

If you activate your DEGIRO investment account before the 1 July 2024, DEGIRO will reimburse your transaction fees up to £100. The following conditions apply to this offer:

  • The offer is valid until (including) 30 June 2024.
  • During the offer period, new clients who have activated an account will receive up to £100 in transaction fees reimbursed.
  • The first transaction costs (commission and external handling fees) up to £100 within the timeframe until 31 July 2024 will be reimbursed.
  • Currency handling fees (Auto FX trader) are not eligible to be refunded with this promotion.
  • We will reimburse the transaction costs and external handling fees you have spent (up to a maximum of £100) to your DEGIRO account in early August 2024.
  • This offer is only valid for new clients with an UK DEGIRO account.
  • To be eligible for this offer, the new client needs to make a first deposit to validate the account (minimum deposit is £0.01) and activate their DEGIRO account.
  • New clients who started their registration before the offer period, but activate their DEGIRO account during the offer period, are also eligible for this offer.
  • If an existing account is already linked to the address of the new client, participation is excluded.
  • Each new client can only claim the £100 transaction credit once.
  • The transaction fees and handling costs are converted and reimbursed in GBP even if they are charged in EUR. The amount that will be reimbursed in GBP is calculated based on the currency exchange rate applicable on the day of reimbursement.
  • Dutch law is applicable to this promotion.

Acceptance of offer conditions

By participating in the offer, the client automatically accepts the offer conditions and terms. DEGIRO may terminate the campaign prematurely or change the campaign conditions. DEGIRO will communicate any changes via the website.

Participation

Participation in the offer is open to all clients who have activated an account at DEGIRO on or before the 30 June 2024.

icon_close